This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Milone MC, O’Doherty U. Clinical use of lentiviral vectors. Leukemia. 2018;32:1529–41.
Wagner J, Wickman E, DeRenzo C, Gottschalk S. CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality? Mol Ther. 2020;28:2320–39.
Kebriaei P, Izsvák Z, Narayanavari SA, Singh H, Ivics Z. Gene Therapy with the Sleeping Beauty Transposon System. Trends Genet. 2017;33:852–70.
Ariza-Heredia EJ, Granwehr BP, Viola GM, Bhatti M, Kelley JM, Kochenderfer J, et al. False-positive HIV nucleic acid amplification testing during CAR T-cell therapy. Diagn Microbiol Infect Dis. 2017;88:305–7.
Hauser JR, Hong H, Babady NE, Papanicolaou GA, Tang Y-W. False-Positive Results for Human Immunodeficiency Virus Type 1 Nucleic Acid Amplification Testing in Chimeric Antigen Receptor T Cell Therapy. J Clin Microbiol. 2020;58:e01420–19.
Laetsch TW, Maude SL, Milone MC, Davis KL, Krueger J, Cardenas AM, et al. False-positive results with select HIV-1 NAT methods following lentivirus-based tisagenlecleucel therapy. Blood. 2018;131:2596–8.
Cornetta K, Duffy L, Turtle CJ, Jensen M, Forman S, Binder-Scholl G, et al. Absence of Replication-Competent Lentivirus in the Clinic: Analysis of Infused T Cell Products. Mol Ther. 2018;26:280–8.
Busch MP, Bloch EM, Kleinman S. Prevention of transfusion-transmitted infections. Blood. 2019;133:1854–64.
De Ravin SS, Gray JT, Throm RE, Spindler J, Kearney M, Wu X, et al. False-positive HIV PCR test following Ex vivo lentiviral gene transfer treatment of X-linked severe combined immunodeficiency vector. Mol Ther. 2014;22:244–5.
D’angelo SP, Melchiori L, Merchant MS, Bernstein D, Glod J, Kaplan R, et al. Antitumor activity associated with prolonged persistence of adoptively transferred NY-ESO-1c259T cells in synovial sarcoma. Cancer Discov. 2018;8:944–57.
Hongeng S, Anurathapan U, Songdej D, Phuphuakrat A, Jongrak K, Parsons G, et al. Wild-type HIV infection after treatment with lentiviral gene therapy for β-thalassemia. Blood Adv. 2021;5:2701–6.
Patel P, Borkowf CB, Brooks JT, Lasry A, Lansky A, Mermin J. Estimating per-act HIV transmission risk: A systematic review. Aids. 2014;28:1509–19.
Author information
Authors and Affiliations
Contributions
MS designed the study, collected data and analyzed data and drafted the manuscript. DA provided critical feedback on the study design and data interpretation. MD collected and analyzed data. BP provided critical feedback on the study design and data interpretation. NA provided critical feedback on the study design and data interpretation. BVT provided critical feedback on the study design and data interpretation. AG designed the study, analyzed data and provided criticla feedback the initial manuscript. All authors criticial reviewed the manuscript and approved the final version.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Slade, M., Araujo, D., Du, M. et al. False-positive human immunodeficiency virus nuclear acid amplification technique testing following therapy with transgenic T cell receptor cellular therapy for synovial sarcoma. Bone Marrow Transplant (2024). https://doi.org/10.1038/s41409-024-02307-1
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41409-024-02307-1